Evaluation of 11C-methionine PET as a surrogate endpoint after treatment of grade 2 gliomas

Journal of Neuro-Oncology

Volumn 71, Issue 3, 2005, Pages 325-332

  Ribom, Dan ^a,b   Schoenmaekers, Marjoleine ^a   Engler, Henry ^c   Smits, Anja ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b Länssjukhuset ^*  (Sweden)

^c Uppsala Imanet AB   (Sweden)

Author keywords

Low grade glioma; Positron emission tomography; Surrogate endpoint

Indexed keywords

COBALT 60; LOMUSTINE; METHIONINE C 11; PROCARBAZINE; VINCRISTINE; CARBON; DIAGNOSTIC AGENT; METHIONINE; RADIOPHARMACEUTICAL AGENT; TRACER; TUMOR MARKER;

ADOLESCENT; ADULT; AGED; ARTICLE; BRAIN SCINTISCANNING; CANCER GRADING; CANCER SURGERY; CLINICAL ARTICLE; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE COURSE; DISEASE SEVERITY; DRUG UPTAKE; FOLLOW UP; GLIOMA; HISTOLOGY; HUMAN; IMAGE ANALYSIS; KAPLAN MEIER METHOD; LINEAR ACCELERATOR; MORTALITY; POSITRON EMISSION TOMOGRAPHY; PROGNOSIS; RADIATION DOSE; RETROSPECTIVE STUDY; STATISTICAL ANALYSIS; SURGICAL TECHNIQUE; SURVIVAL RATE; TREATMENT OUTCOME; TUMOR VOLUME; BRAIN TUMOR; CELL PROLIFERATION; DISEASE FREE SURVIVAL; DRUG EFFECT; EVALUATION; FEMALE; MALE; METABOLISM; METHODOLOGY; MIDDLE AGED; OUTCOME ASSESSMENT; SCINTISCANNING;

ADOLESCENT; ADULT; AGED; CARBON ISOTOPES; CELL PROLIFERATION; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; GLIOMA; HUMANS; MALE; METHIONINE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); POSITRON-EMISSION TOMOGRAPHY; RADIOACTIVE TRACERS; RADIOPHARMACEUTICALS; RETROSPECTIVE STUDIES; SUPRATENTORIAL NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 14944373233     PISSN: 0167594X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11060-004-2031-5     Document Type: Article

References (24)

1. AB Karim D Afra P Cornu N Bleehan S Schraub O Witte De F Darcel S Stenning M Pierart M Glabbeke Van 2002 Randomized trial on the efficacy of radiotherapy for cerebral low-grade glioma in the adult: European Organization for Research and Treatment of Cancer Study 22845 with the Medical Research Council study BRO4: An interim analysis Int J Radiat Oncol Biol Phys 52 316-324
2. AB Karim B Maat R Hatlevoll J Menten EH Rutten DG Thomas F Mascarenhas JC Horiot LM Parvinen M Reijn van JJ Jager MG Fabrini AM Alphen van HP Hamers L Gaspar E Noordman M Pierart M Glabbeke van 1996 A randomized trial on dose-response in radiation therapy of low-grade cerebral glioma: European Organization for Research and Treatment of Cancer (EORTC) Study 22844 Int J Radiat Oncol Biol Phys 36 549-556
3. E Shaw R Arusell B Scheithauer J O'Fallon B O'Neill R Dinapoli D Nelson J Earle C Jones T Cascino D Nichols R Ivnik R Hellman W Curran R Abrams 2002 Prospective randomized trial of low- versus high-dose radiation therapy in adults with supratentorial low-grade glioma: Initial report of a north central cancer treatment group/radiation therapy oncology group/eastern cooperative oncology group study J Clin Oncol 20 2267-2276 10.1200/JCO.2002.09.126 1:STN:280:DC%2BD383ktlektg%3D%3D 11980997
4. KJ Langen H Muhlensiepen M Holscbach H Haautzel P Jansen HH Coenen 2000 Transport mechanisms of 3-[123I]iodo-alpha-methyl-L-tyrosine in human glioma cell line: Comparison with [3H]methyl]-L-methionine J Nucl Med 41 1250-1255 1:CAS:528:DC%2BD3cXlsFWjs7Y%3D 10914918
5. 11C-methionine positron emission tomography and proliferating cell nuclear antigen staining Neurosurg Rev 22 210-214 10.1007/s101430050018 1:STN:280:DC%2BD3c7ksFWgtg%3D%3D 10682929
6. LW Kracht M Friese K Herholz R Schroeder B Bauer A Jacobs WD Heiss 2003 Methyl-[11C]- 1-methionine uptake as measured by positron emission tomography correlates to microvessel density in patients with glioma Eur J Nucl Med Mol Imag 30 868-873 1:CAS:528:DC%2BD3sXjvF2lsL0%3D 12692687
7. O De Witte I Goldberg D Wikler S Rorive P Damhaut M Monclus I Salmon J Brotchi S Goldman 2001 Positron emission tomography with injection of methionine as a prognostic factor in glioma J Neurosurg 95 746-750 11702862
8. D Ribom A Eriksson M Hartman H Engler A Nilsson B Långström H Bolander M Bergström A Smits 2001 Positron emission tomography 11C-methionine and survival in patients with low-grade gliomas Cancer 92 1541-1549 10.1002/ 1097-0142(20010915)92:6<1541::AID-CNCR1480>3.0.CO;2-D 1:STN:280:DC%2BD3MnpsFKhtA%3D%3D 11745233
9. B Kaschten A Stevenaert B Sadzot M Deprez C Degueldre G Del Fiore A Luxen M Reznik 1998 Preoperative evaluation of 54 gliomas by PET with fluorine-18-fluorodeoxyglucose and/or carbon-11-methionine J Nucl Med 39 778-785 1:CAS:528:DyaK1cXjsVShtbY%3D 9591574
10. D Ribom H Engler E Blomquist A Smits 2002 Potential significance of (11)C-methionine PET as a marker for the radiosensitivity of low-grade gliomas Eur J Nucl Med 29 632-640 10.1007/s00259-002-0762-0 1:CAS:528:DC%2BD38XkvFSns7w%3D 11976801
11. J Nuutinen P Sonninen P Lehikoinen E Sutinen R Valavaara E Eronen S Norrgard J Kulmala M Teras H Minn 2000 Radiotherapy treatment planning and long-term follow-up with [(11)C]methionine PET in patients with low-grade astrocytoma [In Process Citation] Int J Radiat Oncol Biol Phys 48 43-52 10.1016/S0360-3016(00)00604-0 1:STN:280:DC%2BD3czps1aruw%3D%3D 10924970
12. DA Karnofsky WH Abelmann LF Craver 1948 The use of nitrogen mustards in the palliative treatment of carcinoma. With particular reference to brochogenoc carcinoma Cancer 1 634-656
13. P Kleihues DN Louis BW Scheithauer LB Rorke G Reifenberger PC Burger WK Cavenee 2002 The WHO classification of tumors of the nervous system J Neuropathol Exp Neurol 61 215-225 discussion 226-219
14. M Bergstrom H Lundqvist K Ericson A Lilja P Johnstrom B Langstrom H Holst von L Eriksson G Blomqvist 1987 Comparison of the accumulation kinetics of L-(methyl-11C)-methionine and D-(methyl-11C)-methionine in brain tumors studied with positron emission tomography Acta Radiol 28 225-229
15. E Mandonnet JY Delattre ML Tanguy KR Swanson AF Carpentier H Duffau P Cornu R Effenterre Van EC Alvord Jr L Capelle 2003 Continuous growth of mean tumor diameter in a subset of grade II gliomas Ann Neurol 53 524-528
16. PL Jager W Vaalburg J Pruim EG Vries de KJ Langen DA Piers 2001 Radiolabeled amino acids: Basic aspects and clinical applications in oncology J Nucl Med 42 432-445 1:CAS:528:DC%2BD3MXmvFOqt7k%3D 11337520
17. WA Weber HJ Wester AL Grosu M Herz B Dzewas HJ Feldmann M Molls G Stocklin M Schwaiger 2000 O-(2-[18F]fluoroethyl)-L-tyrosine and L-[methyl-11C]methionine uptake in brain tumours: Initial results of a comparative study Eur J Nucl Med 27 542-549 10.1007/s002590050541 1:CAS:528:DC%2BD3cXis1Oqtrw%3D 10853810
18. B Pirotte S Goldman P David D Wikler P Damhaut A Vandesteene L Salmon J Brotchi M Levivier 1997 Stereotactic brain biopsy guided by positron emission tomography (PET) with [F-18]fluorodeoxyglucose and [C-11]methionine Acta Neurochir Suppl (Wien) 68 133-138
19. K Herholz T Holzer B Bauer R Schroder J Voges RI Ernestus G Mendoza G Weber-Luxenburger J Lottgen A Thiel K Wienhard WD Heiss 1998 11C-methionine PET for differential diagnosis of low-grade gliomas Neurology 50 1316-1322 1:STN:280:DyaK1c3lsFCiuw%3D%3D 9595980
20. U Roelcke KL Leenders 2001 PET in neuro-oncology J Cancer Res Clin Oncol 127 2-8
21. U Roelcke K Ammon von O Hausmann DL Kaech W Vanloffeld H Landolt JA Rem O Gratzl EW Radu KL Leenders 1999 Operated low grade astrocytomas: A long term PET study on the effect of radiotherapy J Neurol Neurosurg Psychiat 66 644-647
22. J Voges K Herholz T Holzer M Wurker B Bauer U Pietrzyk H Treuer R Schroder V Sturm WD Heiss 1997 11C-methionine and 18F-2-fluorodeoxyglucose positron emission tomography: A tool for diagnosis of cerebral glioma and monitoring after brachytherapy with 125I seeds Stereotact Funct Neurosurg 69 129-135 1:STN:280:DyaK1cznslKhtg%3D%3D 9711745
23. M Wurker K Herholz J Voges U Pietrzyk H Treuer B Bauer V Sturm WD Heiss 1996 Glucose consumption and methionine uptake in low-grade gliomas after iodine-125 brachytherapy Eur J Nucl Med 23 583-586 8698067
24. IR Radford 2002 Imatinib Novartis. Curr Opin Investig Drugs 3 492-499